News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
84.64
-1.24 (-1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
September 01, 2023
The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE (NASDAQ:
Via
Benzinga
Exposures
COVID-19
BioNTech Unusual Options Activity For August 30
August 30, 2023
Via
Benzinga
Why Novavax Stock Was So Healthy on Monday
August 28, 2023
As the coronavirus threat rises, so too does the vaccine maker's value to investors.
Via
The Motley Fool
Exposures
COVID-19
Why BioNTech Shares Are Rising During Monday's Session
August 28, 2023
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S.
Via
Benzinga
Exposures
COVID-19
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
Via
Benzinga
Expert Ratings for BioNTech
August 28, 2023
Via
Benzinga
BioNTech Unusual Options Activity For August 21
August 21, 2023
Via
Benzinga
What's Going On With BioNTech (BNTX) Stock?
August 09, 2023
BioNTech SE - ADR (NASDAQ:BNTX) shares are trading higher by 4.66% to $106.51 Wednesday morning as the stock continues to rebound after falling on Monday.
Via
Benzinga
What's Happening With BioNTech (BNTX) Stock?
August 08, 2023
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 3.28% to $101.73 Tuesday afternoon as the stock rebounds after falling on Monday.
Via
Benzinga
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
August 27, 2023
Can these companies keep up their recent momentum?
Via
The Motley Fool
Exposures
COVID-19
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Via
InvestorPlace
Exposures
COVID-19
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.
Via
The Motley Fool
Exposures
COVID-19
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
August 21, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
August 18, 2023
The companies are hoping to launch their updated Covid shots in September.
Via
Investor's Business Daily
Exposures
COVID-19
BioNTech Se (BNTX) Q2 2023 Earnings Call Transcript
August 07, 2023
BNTX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Why BioNTech Stock Was Sinking Today
August 07, 2023
While the waning of the COVID pandemic is a positive development for the world, it's left the German biotech struggling.
Via
The Motley Fool
Why Moderna Stock Sunk Today
August 07, 2023
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower on Monday.
Via
Benzinga
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies...
Via
Benzinga
Exposures
COVID-19
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
BioNTech Skids As Covid Vaccine-Maker's Sales Plummet And Miss Forecasts
August 07, 2023
The company kept its sales outlook for the year, however.
Via
Investor's Business Daily
Preview: BioNTech's Earnings
August 04, 2023
Via
Benzinga
Analyst Ratings for BioNTech
August 01, 2023
Via
Benzinga
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...
Via
Talk Markets
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
August 11, 2023
Via
Benzinga
Exposures
COVID-19
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
August 07, 2023
Benzinga
Via
Benzinga
BioNTech Slips Into Quarterly Loss As Q2 Revenue Evaporates, Cuts R&D Spending For FY23
August 07, 2023
BioNTech SE (NASDAQ: BNTX) has reported Q2 revenues of €167.7 million, sharply down from €3.2 billion a year ago
Via
Benzinga
US Stocks Eye Rebound After Big Earnings, But Inflation Data Looms: Analyst Says 3 Factors Can Take S&P 500 Past 4,800
August 07, 2023
US stocks look set for a cautious start as the week's inflation data will likely keep traders on tenterhooks.
Via
Benzinga
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
August 03, 2023
The company hopes to launch an updated Covid booster shot this fall. But there are several complications.
Via
Investor's Business Daily
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.